This project will utilise the information from the determination of the complete genome sequence of Leptospira borgpetersenii serovar Hardjobovis at Monash University. Bioinformations analysis will be used to allow a global approach to idenitfy all putative vaccine antigens. Using the hight throughput protein production unit at Monash University, candidiate proteins will be cloned, expressed and purified and their productive capacity investigated.
|Effective start/end date||1/01/06 → 31/12/08|
- Australian Research Council (ARC): AUD510,000.00
- Pfizer Australia Pty Limited: AUD339,000.00
- Pfizer Australia Pty Limited: AUD48,033.00